- New Purchases: AGN, SIEN, AMRN, WMGI,
- Added Positions: BHVN, EIGR, HRTX, SSKN, RTRX, OPTN,
- Reduced Positions: IOVA, CPRX, ADMS, NVRO, LJPC, NSTG, GBT, QTNT, MYGN, INCY, ADMA, ATRS, MTNB, REPH, ZGNX, SBBP, SLGL, DXCM, BDSI, VCEL,
- Sold Out: ACRS, MRTX, XENT, SRRA, IART, LIVN, NEOS, TLGT, ATEC, OPNT, OSMT, NVLN,
For the details of Broadfin Capital, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/broadfin+capital%2C+llc/current-portfolio/portfolio
These are the top 5 holdings of Broadfin Capital, LLC- Iovance Biotherapeutics Inc (IOVA) - 1,559,299 shares, 8.43% of the total portfolio. Shares reduced by 63.97%
- Aratana Therapeutics Inc (PETX) - 7,258,135 shares, 8.26% of the total portfolio.
- Nevro Corp (NVRO) - 488,265 shares, 6.98% of the total portfolio. Shares reduced by 21.58%
- Biohaven Pharmaceutical Holding Co Ltd (BHVN) - 676,879 shares, 6.54% of the total portfolio. Shares added by 174.15%
- Retrophin Inc (RTRX) - 1,053,314 shares, 4.67% of the total portfolio. Shares added by 3.66%
Broadfin Capital, LLC initiated holding in Allergan PLC. The purchase prices were between $115.73 and $167.43, with an estimated average price of $138.45. The stock is now traded at around $157.92. The impact to a portfolio due to this purchase was 4.24%. The holding were 114,804 shares as of .
New Purchase: Sientra Inc (SIEN)Broadfin Capital, LLC initiated holding in Sientra Inc. The purchase prices were between $5.43 and $9.06, with an estimated average price of $7.2. The stock is now traded at around $6.84. The impact to a portfolio due to this purchase was 1.9%. The holding were 1,400,000 shares as of .
New Purchase: Amarin Corp PLC (AMRN)Broadfin Capital, LLC initiated holding in Amarin Corp PLC. The purchase prices were between $16.27 and $20.51, with an estimated average price of $18.3. The stock is now traded at around $14.91. The impact to a portfolio due to this purchase was 1.24%. The holding were 291,000 shares as of .
New Purchase: Wright Medical Group NV (WMGI)Broadfin Capital, LLC initiated holding in Wright Medical Group NV. The purchase prices were between $27.8 and $32.5, with an estimated average price of $30.47. The stock is now traded at around $21.21. The impact to a portfolio due to this purchase was 0.83%. The holding were 126,400 shares as of .
Added: Biohaven Pharmaceutical Holding Co Ltd (BHVN)Broadfin Capital, LLC added to a holding in Biohaven Pharmaceutical Holding Co Ltd by 174.15%. The purchase prices were between $39.79 and $67.01, with an estimated average price of $56.51. The stock is now traded at around $38.68. The impact to a portfolio due to this purchase was 4.15%. The holding were 676,879 shares as of .
Added: Eiger BioPharmaceuticals Inc (EIGR)Broadfin Capital, LLC added to a holding in Eiger BioPharmaceuticals Inc by 756.77%. The purchase prices were between $9.54 and $14.96, with an estimated average price of $11.53. The stock is now traded at around $10.12. The impact to a portfolio due to this purchase was 3.42%. The holding were 1,656,137 shares as of .
Added: Heron Therapeutics Inc (HRTX)Broadfin Capital, LLC added to a holding in Heron Therapeutics Inc by 216.35%. The purchase prices were between $16.93 and $26.22, with an estimated average price of $20. The stock is now traded at around $16.94. The impact to a portfolio due to this purchase was 1.85%. The holding were 657,998 shares as of .
Sold Out: Aclaris Therapeutics Inc (ACRS)Broadfin Capital, LLC sold out a holding in Aclaris Therapeutics Inc. The sale prices were between $2.13 and $7.06, with an estimated average price of $5.45.
Sold Out: Mirati Therapeutics Inc (MRTX)Broadfin Capital, LLC sold out a holding in Mirati Therapeutics Inc. The sale prices were between $59.49 and $104.71, with an estimated average price of $77.61.
Sold Out: Intersect ENT Inc (XENT)Broadfin Capital, LLC sold out a holding in Intersect ENT Inc. The sale prices were between $22.43 and $33.65, with an estimated average price of $26.98.
Sold Out: Sierra Oncology Inc (SRRA)Broadfin Capital, LLC sold out a holding in Sierra Oncology Inc. The sale prices were between $0.56 and $1.7, with an estimated average price of $1.22.
Sold Out: Integra Lifesciences Holdings Corp (IART)Broadfin Capital, LLC sold out a holding in Integra Lifesciences Holdings Corp. The sale prices were between $46.45 and $55.85, with an estimated average price of $51.45.
Sold Out: LivaNova PLC (LIVN)Broadfin Capital, LLC sold out a holding in LivaNova PLC. The sale prices were between $66.45 and $97.36, with an estimated average price of $73.07.
Reduced: Iovance Biotherapeutics Inc (IOVA)Broadfin Capital, LLC reduced to a holding in Iovance Biotherapeutics Inc by 63.97%. The sale prices were between $9.78 and $24.52, with an estimated average price of $15.03. The stock is now traded at around $20.76. The impact to a portfolio due to this sale was -5.44%. Broadfin Capital, LLC still held 1,559,299 shares as of .
Reduced: Catalyst Pharmaceuticals Inc (CPRX)Broadfin Capital, LLC reduced to a holding in Catalyst Pharmaceuticals Inc by 52.79%. The sale prices were between $2.7 and $6.11, with an estimated average price of $4.32. The stock is now traded at around $5.58. The impact to a portfolio due to this sale was -3.26%. Broadfin Capital, LLC still held 2,765,070 shares as of .
Reduced: Adamas Pharmaceuticals Inc (ADMS)Broadfin Capital, LLC reduced to a holding in Adamas Pharmaceuticals Inc by 82.14%. The sale prices were between $4.29 and $7.24, with an estimated average price of $5.75. The stock is now traded at around $6.65. The impact to a portfolio due to this sale was -2.98%. Broadfin Capital, LLC still held 441,088 shares as of .
Reduced: Nevro Corp (NVRO)Broadfin Capital, LLC reduced to a holding in Nevro Corp by 21.58%. The sale prices were between $58.04 and $66.99, with an estimated average price of $62.27. The stock is now traded at around $81.65. The impact to a portfolio due to this sale was -1.73%. Broadfin Capital, LLC still held 488,265 shares as of .
Reduced: La Jolla Pharmaceutical Co (LJPC)Broadfin Capital, LLC reduced to a holding in La Jolla Pharmaceutical Co by 55.3%. The sale prices were between $5.32 and $12.86, with an estimated average price of $7.5. The stock is now traded at around $9.79. The impact to a portfolio due to this sale was -1.47%. Broadfin Capital, LLC still held 891,760 shares as of .
Reduced: NanoString Technologies Inc (NSTG)Broadfin Capital, LLC reduced to a holding in NanoString Technologies Inc by 78.98%. The sale prices were between $23.35 and $30.35, with an estimated average price of $26.46. The stock is now traded at around $27.23. The impact to a portfolio due to this sale was -1.39%. Broadfin Capital, LLC still held 74,786 shares as of .
Here is the complete portfolio of Broadfin Capital, LLC. Also check out:
1. Broadfin Capital, LLC's Undervalued Stocks
2. Broadfin Capital, LLC's Top Growth Companies, and
3. Broadfin Capital, LLC's High Yield stocks
4. Stocks that Broadfin Capital, LLC keeps buying